SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000920465-14-000089
Filing Date
2014-07-29
Accepted
2014-07-29 16:26:28
Documents
4
Period of Report
2014-07-29
Effectiveness Date
2014-07-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy2014def.htm DEF 14A 478745
2 image1.jpg GRAPHIC 164429
3 lajolla2014card.jpg GRAPHIC 1768584
4 lajolla2014cardpage2.jpg GRAPHIC 830649
  Complete submission text file 0000920465-14-000089.txt   4287914
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36282 | Film No.: 141000118
SIC: 2836 Biological Products, (No Diagnostic Substances)